BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khanfar MA, Reiner D, Hagenow S, Stark H. Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H3R ligands. Bioorg Med Chem 2018;26:4034-46. [PMID: 29960729 DOI: 10.1016/j.bmc.2018.06.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sergeeva OA, Mazur K, Reiner-Link D, Lutsenko K, Haas HL, Alfonso-Prieto M, Stark H. OLHA (Nα-oleoylhistamine) modulates activity of mouse brain histaminergic neurons. Neuropharmacology 2022;215:109167. [PMID: 35750238 DOI: 10.1016/j.neuropharm.2022.109167] [Reference Citation Analysis]
2 Ghamari N, Kouhi Hargelan S, Zivkovic A, Leitzbach L, Dastmalchi S, Stark H, Hamzeh-Mivehroud M. Guided rational design with scaffold hopping leading to novel histamine H3 receptor ligands. Bioorg Chem 2021;117:105411. [PMID: 34653944 DOI: 10.1016/j.bioorg.2021.105411] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Łażewska D, Zaręba P, Godyń J, Doroz-Płonka A, Frank A, Reiner-Link D, Bajda M, Stary D, Mogilski S, Olejarz-Maciej A, Kaleta M, Stark H, Malawska B, Kieć-Kononowicz K. Biphenylalkoxyamine Derivatives-Histamine H3 Receptor Ligands with Butyrylcholinesterase Inhibitory Activity. Molecules 2021;26:3580. [PMID: 34208297 DOI: 10.3390/molecules26123580] [Reference Citation Analysis]
4 Kuder KJ, Kotańska M, Szczepańska K, Mika K, Reiner-Link D, Stark H, Kieć-Kononowicz K. Discovery of Potential, Dual-Active Histamine H3 Receptor Ligands with Combined Antioxidant Properties. Molecules 2021;26:2300. [PMID: 33921144 DOI: 10.3390/molecules26082300] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Li JQ, Sun LY, Jiang Z, Chen C, Gao H, Chigan JZ, Ding HH, Yang KW. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors. Bioorg Chem 2021;107:104576. [PMID: 33383326 DOI: 10.1016/j.bioorg.2020.104576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Xiao F, Yan R, Zhang Y, Wang S, Chen S, Zhou N, Deng X. Synthesis and antiseizure effect evaluation of nonimidazole histamine H3 receptor antagonists containing the oxazole moiety. Arch Pharm (Weinheim) 2021;354:e2000298. [PMID: 33325568 DOI: 10.1002/ardp.202000298] [Reference Citation Analysis]
7 Reiner D, Zivkovic A, Labeeuw O, Krief S, Capet M, Stark H. Novel pyrrolidinone derivative lacks claimed histamine H3 receptor stimulation in receptor binding and functional studies. Eur J Med Chem 2020;191:112150. [PMID: 32105981 DOI: 10.1016/j.ejmech.2020.112150] [Reference Citation Analysis]
8 Lutsenko K, Hagenow S, Affini A, Reiner D, Stark H. Rasagiline derivatives combined with histamine H3 receptor properties. Bioorganic & Medicinal Chemistry Letters 2019;29:126612. [DOI: 10.1016/j.bmcl.2019.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
9 Schaller D, Hagenow S, Stark H, Wolber G. Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands. PLoS One 2019;14:e0218820. [PMID: 31237914 DOI: 10.1371/journal.pone.0218820] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
10 Szczepańska K, Karcz T, Siwek A, Kuder KJ, Latacz G, Bednarski M, Szafarz M, Hagenow S, Lubelska A, Olejarz-Maciej A, Sobolewski M, Mika K, Kotańska M, Stark H, Kieć-Kononowicz K. Structural modifications and in vitro pharmacological evaluation of 4-pyridyl-piperazine derivatives as an active and selective histamine H3 receptor ligands. Bioorg Chem 2019;91:103071. [PMID: 31362197 DOI: 10.1016/j.bioorg.2019.103071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
11 Zarnegar Z, Shokrani Z, Safari J. Asparagine functionalized Al2O3 nanoparticle as a superior heterogeneous organocatalyst in the synthesis of 2-aminothiazoles. Journal of Molecular Structure 2019;1185:143-52. [DOI: 10.1016/j.molstruc.2019.02.080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Reiner D, Stark H. Ligand binding kinetics at histamine H3 receptors by fluorescence-polarization with real-time monitoring. European Journal of Pharmacology 2019;848:112-20. [DOI: 10.1016/j.ejphar.2019.01.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Ghamari N, Zarei O, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M. Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects. Chem Biol Drug Des 2019;93:832-43. [PMID: 30586225 DOI: 10.1111/cbdd.13471] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]